Vero biotech is an emerging biotechnology company focused on the design, development, and commercialization of next-generation inhaled nitric oxide (NO) delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions.


Pharmaceutical

Vero Biotech

Brent Furse

Kyle Galenski

Jeff Dail

Diego Vargas

Kevin Stout

Kevin Dolan

Jeff Bruner

Christopher Dumadag

Molly Gannett Rrt-Nps

Brian Cugliari

Clayton Santiago

Robyn McClure

Jason Molinari

Michael Landis Phr

Kevin Friedman Do

Eric S. Finkelman

Judson Boothe

Namita Khanna

Michelle Nickoli

Nate Pinkard

The New Product Development team at Vero Biotech is responsible for the conceptualization, design, and advancement of innovative inhaled nitric oxide (NO) delivery systems. Their multidisciplinary approach emphasizes research, clinical validation, and the integration of cutting-edge automation technologies to bring new cardiopulmonary therapies from ideation to market, addressing critical patient needs.

New Product Development

Engineering

Sales Team

Strategic and Regulatory Development

New Product Development

About

Team members

Other teams at Vero Biotech

Engineering

Sales Team

Strategic and Regulatory Development